<p>Aiosyn develops AI software that helps pathologists make faster and more accurate diagnoses. The solution addresses the expected sharp increase in the number of cancer patients and the simultaneous growing shortage of pathologists, which is further increasing their workload. The software helps them perform their work more efficiently and accurately. The company name refers to artificial intelligence and eosin, a commonly used stain for pathological tissue sections. Aiosyn is a spin-off of Radboudumc.</p><p>CEO/founder: Jeroen van der Laak</p>

Sector

Health

Aiosyn (1) (1).jpg

Aiosyn

Aiosyn develops AI software that helps pathologists deliver faster and more accurate diagnoses. The solution addresses the expected sharp increase in the number of cancer patients and the simultaneous growing shortage of pathologists, which is further increasing their workload. 